Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 579, doi. 10.1177/10600280221130450
- By:
- Publication type:
- Article
Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 5
Results: 15
1
2
Fatal COVID-19 Pneumonia in a Rheumatoid Arthritis Patient Receiving Long-Term Rituximab Therapy.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
3
Challenges With Using a Weight-Based Approach to Bolus Fluid Dosing in Obese Critically Ill Patients.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 609, doi. 10.1177/10600280221125169
- By:
- Publication type:
- Article
4
Should We Account Valproate Therapeutic Failure Only to Drug Potency If We Still Cannot Measure Liquid Medications Properly?
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
5
Intranasal Olopatadine-Mometasone in the Treatment of Seasonal Allergic Rhinitis.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 570, doi. 10.1177/10600280221124230
- By:
- Publication type:
- Article
6
Considerations for the Role of the Pharmacist in Managing Patients on Eculizumab for Hematopoietic Stem Cell Transplantation–Related Thrombotic Microangiopathy.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 622, doi. 10.1177/10600280221123089
- By:
- Publication type:
- Article
7
Pharmacist-Driven Methicillin-Resistant S. aureus Polymerase Chain Reaction Testing for Pneumonia.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 560, doi. 10.1177/10600280221121144
- By:
- Publication type:
- Article
8
Effectiveness, Safety, and Predictors of Response to 5% Lidocaine-Medicated Plaster for the Treatment of Patients With Trigeminal Neuralgia: A Retrospective Study.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 527, doi. 10.1177/10600280221120457
- By:
- Publication type:
- Article
9
Perioperative Antiplatelet Bridging With Cangrelor: A Cohort Study and Narrative Review.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 544, doi. 10.1177/10600280221120310
- By:
- Publication type:
- Article
10
Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 535, doi. 10.1177/10600280221120211
- By:
- Publication type:
- Article
11
Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 553, doi. 10.1177/10600280221120059
- By:
- Publication type:
- Article
12
Rate of Inpatient Hypoglycemia Following a 1:1 Dose Interchange Between Concentrated Insulin Glargine to Insulin Detemir.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 513, doi. 10.1177/10600280221119187
- By:
- Publication type:
- Article
13
Maribavir for the Management of Cytomegalovirus in Adult Transplant Recipients: A Review of the Literature and Practical Considerations.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 597, doi. 10.1177/10600280221118959
- By:
- Publication type:
- Article
14
Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 521, doi. 10.1177/10600280221118903
- By:
- Publication type:
- Article
15
A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 5, p. 585, doi. 10.1177/10600280221118370
- By:
- Publication type:
- Article